EXACT Sciences (EXAS) Names John Bakewell Chief Financial Officer

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS) today announced the appointment of John K. Bakewell as chief financial officer. Mr. Bakewell will begin his new role on January 1, 2016.

"John brings significant industry and public company experience and financial acumen to Exact Sciences," said Kevin T. Conroy, chairman, president and CEO of Exact Sciences.

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.